Back to Search
Start Over
Improving risk stratification for cardiovascular disease
- Source :
- Expert review of cardiovascular therapy, 8(8), 1091-1093. Taylor and Francis Ltd.
- Publication Year :
- 2010
-
Abstract
- Evaluation of: Heslop CL, Frohlich JJ, Hill JS. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. J. Am. Coll. Cardiol. 55(11), 1102–1109 (2010).Identifying people at high risk of cardiovascular events is the cornerstone of cardiovascular disease prevention and a major challenge for healthcare worldwide. Recently, both inflammatory and oxidative markers have been shown to improve cardiovascular risk prediction models in a wide range of patients. Here, we evaluate a recent publication investigating the value of inflammatory and oxidative markers for the prediction of cardiovascular mortality in patients with stable coronary artery disease. This study shows that the use of multiple markers may increase the predictive power of traditional risk models. The findings are discussed in the context of cardiovascular risk prediction in general.
- Subjects :
- medicine.medical_specialty
Framingham Risk Score
biology
business.industry
C-reactive protein
Context (language use)
General Medicine
Disease
medicine.disease
Coronary artery disease
Internal medicine
Risk stratification
Internal Medicine
medicine
Cardiology
biology.protein
In patient
Cardiology and Cardiovascular Medicine
business
Cardiovascular mortality
Subjects
Details
- Language :
- English
- ISSN :
- 14779072
- Database :
- OpenAIRE
- Journal :
- Expert review of cardiovascular therapy, 8(8), 1091-1093. Taylor and Francis Ltd.
- Accession number :
- edsair.doi.dedup.....f751b2824b0ae6f37611e492a9be4281